跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,936 条关于
“NPM1-mutated acute leukemia”
全部
36,936
临床试验
32,048
药物
371
机构
36
资讯
4,481
3年前
Revumenib Shows Promise in Phase 1 Trial for KMT2A-Rearranged and NPM1-Mutated Acute Leukemia
9个月前
FDA Approves Ziftomenib, First-in-Class Targeted Therapy for NPM1-Mutated Acute Myeloid Leukemia
10个月前
FDA Approves Komzifti as First Once-Daily Oral Menin Inhibitor for Relapsed NPM1-Mutated AML
去年
Revumenib Shows Promise in Relapsed/Refractory NPM1-Mutated AML
上个月
Beyang Therapeutics Closes Oversubscribed $30 Million Series A to Advance AI-Driven Drug Pipeline
9个月前
Kura Oncology Receives $135 Million Milestone Payment as KOMZIFTI Achieves First Commercial Sale
去年
Kura Oncology Poised for Growth with Promising Zifto Data and Strong Financials
5个月前
Kura Oncology to Present Updated Darlifarnib Combination Data for Renal Cell Carcinoma at IKCS Europe 2026
去年
FDA Approves Revumenib for Relapsed/Refractory KMT2A-Rearranged Acute Leukemia
去年
Bleximenib Shows Promising Results in Advanced Acute Leukemia Trial with KMT2A and NPM1 Mutations
第 1 页，共 449 页
上一页
下一页
